Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors-Reference-Cited by-同舟云学术

Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors

Published:2017-06 Issue:3 Volume:145 Page:413-419
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Garcia-Soto Arlene E.,Schreiber Taylor,Strbo Natasa,Ganjei-Azar Parvin,Miao Feng,Koru-Sengul Tulay,Simpkins Fiona,Nieves-Neira Wilberto^ORCID,Lucci Joseph,Podack Eckhard R.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference32 articles.

1. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulartory T cell ratio are associated with favorable prognosis in ovarian cancer;Sato;Proc. Natl. Acad. Sci.,2005

2. Prognostic significance of tumor-infiltrating T-lymphocytes, recurrence, and survival in epithelial ovarian cancer;Zhang;N. Engl. J. Med.,2003

3. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival;Curiel;Nat. Med.,2004

4. Prognostic significance of tumor-infiltrating T –lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer;Leffers;Cancer Immunol. Immunother.,2009

5. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer;Odunsi;Cancer Res.,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential value of cancer‐testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy;Immunity, Inflammation and Disease;2024-06

2. Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens;International Journal of Molecular Sciences;2023-01-24

3. From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy;Frontiers in Chemistry;2023-01-17

4. Role of immunotherapy in ovarian cancer: a narrative review;Gynecology and Pelvic Medicine;2022-12

5. The Use of Immunotherapy for Treatment of Gynecologic Malignancies;Ovarian Cancer;2022-08-06